SAN ANTONIO--(BUSINESS WIRE)--KCI, an Acelity Company, announced today that recently published data stemming from two studies demonstrate that closed incision negative pressure therapy (ciNPT) with ...
The PREVENA RESTOR™ Therapy portfolio optimizes post-operative care by delivering negative pressure therapy to the incision and surrounding soft tissue to enhance recovery ST. PAUL, Minn.--(BUSINESS ...
New guidance highlights evolving surgical procedure applications of reticulated open cell foam (ROCF) dressings to support patient safety, surgical outcomes and future standards of care Solventum™ ...
Research presented at the 30th American Association of Hip and Knee Surgeons Annual Meeting (AAHKS) builds on existing evidence that PREVENA™ Therapy lowers surgical site complications and readmission ...
SAN ANTONIO--(BUSINESS WIRE)--KCI, an Acelity Company, today announced the availability of two additional PREVENA™ Therapy offerings in Europe: the PREVENA DUO™ Incision Management System with PEEL & ...
The top concerns for most surgeons today are post-operative complications and infections. Negative pressure therapy promises to help surgeons reduce these risks and their associated costs. During a ...
Please provide your email address to receive an email when new articles are posted on . According to study results, patients who underwent direct-anterior approach total hip arthroplasty and had ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Use of closed-incision negative pressure therapy had no significant difference in wound complication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results